Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Teva Pharmaceuticals Industries Limited went halfway around the world to make the largest acquisition ever by an Israeli company. On Halloween, the Petach Tikva, Israel�based maker of generic drugs announced that it planned to buy Irvine, California � based rival Sicor Inc. for $3.4 billion in cash and stock. Teva will pay $16.50 in cash and 0.1906 Teva American Depositary Receipts for each Sicor share. With Teva’s share price hovering between $55 and $60 a share in the two months after the deal was announced, the company will pay about $27.50 a share for Sicor. The companies hope to close the deal in the first quarter, pending regulatory approval and a mid-January vote by Sicor shareholders. For acquiror Teva Pharmaceuticals Industries Limited (Petach Tikva, Israel) In-house: At the parent company: general counsel Uzi Karniel and assistant general counsel Dov Bergwerk. At Teva Pharmaceuticals USA: general counsel Richard Egosi and directors of legal affairs Brian Shanahan and David Stark. Willkie Farr & Gallagher (New York): Corporate and financial services: Jeffrey Hochman, Peter Jakes, special counsel Jonathan Konoff, and associates Laly David, Christine DiVincent, Frank Gerhard, Eran Sarig, and Dong Shon. Executive compensation and employee benefits: Frank Daniele and associate David Rubinsky. Tax: Andrew Needham and associate Eric Rosenoff. Environmental: E. Donald Elliott and associate Arthur Rheingold. Telecommunications: Theodore Whitehouse. Real estate: associate Moishie Klein. (Elliott and Whitehouse are in Washington, D.C.) Willkie has represented Teva since 1982. Sonnenschein Nath & Rosenthal (Chicago): Corporate: Ira Schreger. Intellectual property: G. Harley Blosser, of counsel Margaret Dunbar, and associate Daniel Celander. Health care: Bruce Fried, T. Reed Stephens, and associate Daniel Body. Food and drug law: associate Christopher Brown. (Schreger is in New York. Blosser, Body, and Celander are in St. Louis. Dunbar is in Los Angeles. Fried, Stephens, and Brown are in Washington, D.C.) Schreger has represented Teva for five years, first at New York boutique Schneck Weltman & Hashmall, which represented Teva in the fen-phen class action litigation over the use of diet drugs. Goodwin Procter acquired Schneck in 2001, and Schreger moved to Sonnenschein last year, taking Teva with him. For target SICOR Inc. (Irvine, California) In-house: Senior legal counsel Wesley Fach. Pillsbury Winthrop (San Francisco): Corporate and securities: Kenneth Adelsberg, Stephen Rusmisel, Babak “Bo” Yaghmaie, and associates Donovan Burke, Ann-Charlotte Engstrom, Jeremy Harris, Jeanie Park, Lindsay Robbins, and Kenneth Yi. Litigation: David Lindley, counsel Aileen “Chuca” Meyer, and associates Steven Dahm, Bryan Dunlap, Todd Friedland, Amy Gross, Shelley Orcutt, and LaShonne Watts. Life sciences and technology: Kirke Hasson, Cameo Jones, Thomas Sparks, Jr., and associates Harpreet Bal, Alan Smith, Kristin Van Vleck, and Donyelle Werner. Tax and benefits: Keith Gercken. Executive compensation and benefits: Peter Hunt. Intellectual property: associate Amyt Eckstein. Employment and labor: associate David Lagasse. (Adelsberg, Rusmisel, Yaghmaie, Burke, Engstrom, Harris, Park, Yi, Lindley, Dunlap, Gross, Watts, Hunt, Eckstein, and Lagasse are in New York. Meyer and Dahm are in Washington, D.C. Friedland and Orcutt are in Costa Mesa, California.) Pillsbury Winthrop has represented Sicor since the company’s 1986 incorporation. Efrati, Galili & Co. (Tel Aviv): Corporate and M&A: Alon Galili, Ian Rostowsky, and associates Maya Lakstein and Keren Mozes-Michaeli. Environmental: associate Merav Niv-Geva. Pillsbury referred the Israeli work on the deal to Efrati, Galili. Paul, Hastings, Janofsky & Walker (Los Angeles): Patent: Jessica Wolff and associate Richard Pagliery. Litigation: associate Joseph Warren. (All are in San Diego.) Wolff has represented Sicor on patent law issues for about a decade. For Sicor minority shareholder Carlo Silva Simpson Thacher & Bartlett (New York): M&A: Alan Klein and associates Ellen Patterson and Jeffrey Symons. Klein represented Silva seven years ago in the merger of his Milan-based company, Sicor s.p.a., with U.S. public company Gensia Inc., a deal that formed Sicor Inc., and has continued to represent him on Sicor matters.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.